The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as alternatives to animal testing in preclinical drug developmen ...

Non-animal testing methods could save drugmakers time and money, officials say ...

A new technical paper, “Towards Structured Training and Validation of AI-based Systems with Digital Twin Scenarios,” was ...

The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new biotechnology methods instead to spur innovation in the pharmaceutical ...

Defence AI teams are turning to synthetic data because real operational data can be scarce, sensitive, or hard to move. But synthetic data only helps if you can show it represents the real conditions ...

Delivers unified Synopsys-Ansys workflows that bring together previously separate engineering processes to create more cohesive and efficient product development ...

In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...

The OpenFold Consortium today announced a major OpenFold3 update and the public release of training datasets and full-stack tooling for reproducible biomolecular AI. OpenFold3 is an open-source deep ...

New design, verification and simulation solutions to re-engineer AI-powered product innovation at Synopsys Converge 2026.

Around 20–40% of the general population are estimated to have insulin resistance—a condition where insulin begins to be less ...

Methods developed and validated to establish the "World Bank of NK Cells" from healthy donors and cancer patients -- Single apheresis yields up to 5 billion (5×109) highly pure activated memory ...

BackgroundWater scarcity, declining water quality, and increasing climate variability are imposing unprecedented constraints on global food production, ...